Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(galantamine). Showing records 1 – 20 of 20 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Tampere University

1. Dania, Anna. The efficacy of a combination therapy with memantine and an acetylcholinesterase inhibitor in alzheimer's disease: a systematic review and meta-analysis .

Degree: 2014, Tampere University

 Background: To date, clinical trials have reported inconsistent results on the efficacy of the combination therapy of Memantine plus an acetylcholinesterase inhibitor (AChEI) over a… (more)

Subjects/Keywords: Acetylcholinesterase inhibitor; Alzheimer s disease; donepezil; galantamine; memantine; rivastigmine; meta-analysis.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dania, A. (2014). The efficacy of a combination therapy with memantine and an acetylcholinesterase inhibitor in alzheimer's disease: a systematic review and meta-analysis . (Masters Thesis). Tampere University. Retrieved from https://trepo.tuni.fi/handle/10024/96082

Chicago Manual of Style (16th Edition):

Dania, Anna. “The efficacy of a combination therapy with memantine and an acetylcholinesterase inhibitor in alzheimer's disease: a systematic review and meta-analysis .” 2014. Masters Thesis, Tampere University. Accessed January 23, 2020. https://trepo.tuni.fi/handle/10024/96082.

MLA Handbook (7th Edition):

Dania, Anna. “The efficacy of a combination therapy with memantine and an acetylcholinesterase inhibitor in alzheimer's disease: a systematic review and meta-analysis .” 2014. Web. 23 Jan 2020.

Vancouver:

Dania A. The efficacy of a combination therapy with memantine and an acetylcholinesterase inhibitor in alzheimer's disease: a systematic review and meta-analysis . [Internet] [Masters thesis]. Tampere University; 2014. [cited 2020 Jan 23]. Available from: https://trepo.tuni.fi/handle/10024/96082.

Council of Science Editors:

Dania A. The efficacy of a combination therapy with memantine and an acetylcholinesterase inhibitor in alzheimer's disease: a systematic review and meta-analysis . [Masters Thesis]. Tampere University; 2014. Available from: https://trepo.tuni.fi/handle/10024/96082


University of Miami

2. Morton, Terrell R. Increased Acetylcholinesterase Expression Through Pharmacological Chaperones.

Degree: MS, Neuroscience (Medicine), 2013, University of Miami

  Acetylcholinesterase (AChE) is the enzyme that functions in terminating neurotransmission by hydrolyzing acetylcholine (ACh) in the central and peripheral nervous systems. Like all exportable… (more)

Subjects/Keywords: Acetylcholinesterase; Pharmacological Chaperones; Donepezil; Acetylcholinesterase Inhibitors; Galantamine; Tacrine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Morton, T. R. (2013). Increased Acetylcholinesterase Expression Through Pharmacological Chaperones. (Thesis). University of Miami. Retrieved from https://scholarlyrepository.miami.edu/oa_theses/443

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Morton, Terrell R. “Increased Acetylcholinesterase Expression Through Pharmacological Chaperones.” 2013. Thesis, University of Miami. Accessed January 23, 2020. https://scholarlyrepository.miami.edu/oa_theses/443.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Morton, Terrell R. “Increased Acetylcholinesterase Expression Through Pharmacological Chaperones.” 2013. Web. 23 Jan 2020.

Vancouver:

Morton TR. Increased Acetylcholinesterase Expression Through Pharmacological Chaperones. [Internet] [Thesis]. University of Miami; 2013. [cited 2020 Jan 23]. Available from: https://scholarlyrepository.miami.edu/oa_theses/443.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Morton TR. Increased Acetylcholinesterase Expression Through Pharmacological Chaperones. [Thesis]. University of Miami; 2013. Available from: https://scholarlyrepository.miami.edu/oa_theses/443

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Australian National University

3. Gallagher, Ryan. Development of alkaloid derivatives to probe novel α4β2 nicotinic acetylcholine receptor (nAChR) binding sites .

Degree: 2015, Australian National University

 Nicotinic acetylcholine receptors (nAChRs) are a complex class of ligand gated ion channels consisting of multiple subtypes with different stoichiometries. Of these, the two most… (more)

Subjects/Keywords: nicotinic acetylcholine receptors; nAChRs; methyllycaconitine; substituted cysteine accessibility method; positive allosteric modulators; galanthamine; galantamine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gallagher, R. (2015). Development of alkaloid derivatives to probe novel α4β2 nicotinic acetylcholine receptor (nAChR) binding sites . (Thesis). Australian National University. Retrieved from http://hdl.handle.net/1885/104843

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gallagher, Ryan. “Development of alkaloid derivatives to probe novel α4β2 nicotinic acetylcholine receptor (nAChR) binding sites .” 2015. Thesis, Australian National University. Accessed January 23, 2020. http://hdl.handle.net/1885/104843.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gallagher, Ryan. “Development of alkaloid derivatives to probe novel α4β2 nicotinic acetylcholine receptor (nAChR) binding sites .” 2015. Web. 23 Jan 2020.

Vancouver:

Gallagher R. Development of alkaloid derivatives to probe novel α4β2 nicotinic acetylcholine receptor (nAChR) binding sites . [Internet] [Thesis]. Australian National University; 2015. [cited 2020 Jan 23]. Available from: http://hdl.handle.net/1885/104843.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gallagher R. Development of alkaloid derivatives to probe novel α4β2 nicotinic acetylcholine receptor (nAChR) binding sites . [Thesis]. Australian National University; 2015. Available from: http://hdl.handle.net/1885/104843

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Kentucky

4. Charriez, Christina Margaret. ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR REGULATION IN EXPERIMENTAL NEURODEGENERATIVE DISEASE.

Degree: 2010, University of Kentucky

 The α7 nicotinic acetylcholine receptor (nAChR) is involved in learning and memory, synaptic plasticity, neuroprotection, inflammation, and presynaptic regulation of neurotransmitter release. Alzheimer’s disease (AD),… (more)

Subjects/Keywords: Nicotinic Acetylcholine Receptor; Alzheimer’s Disease; Traumatic Brain Injury; Beta-amyloid; Galantamine; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Charriez, C. M. (2010). ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR REGULATION IN EXPERIMENTAL NEURODEGENERATIVE DISEASE. (Doctoral Dissertation). University of Kentucky. Retrieved from https://uknowledge.uky.edu/gradschool_diss/19

Chicago Manual of Style (16th Edition):

Charriez, Christina Margaret. “ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR REGULATION IN EXPERIMENTAL NEURODEGENERATIVE DISEASE.” 2010. Doctoral Dissertation, University of Kentucky. Accessed January 23, 2020. https://uknowledge.uky.edu/gradschool_diss/19.

MLA Handbook (7th Edition):

Charriez, Christina Margaret. “ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR REGULATION IN EXPERIMENTAL NEURODEGENERATIVE DISEASE.” 2010. Web. 23 Jan 2020.

Vancouver:

Charriez CM. ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR REGULATION IN EXPERIMENTAL NEURODEGENERATIVE DISEASE. [Internet] [Doctoral dissertation]. University of Kentucky; 2010. [cited 2020 Jan 23]. Available from: https://uknowledge.uky.edu/gradschool_diss/19.

Council of Science Editors:

Charriez CM. ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR REGULATION IN EXPERIMENTAL NEURODEGENERATIVE DISEASE. [Doctoral Dissertation]. University of Kentucky; 2010. Available from: https://uknowledge.uky.edu/gradschool_diss/19

5. Lecouflet, Pierre. Intérêts des récepteurs 5-HT4 dans la pathologie Alzmeimer : étude préclinique comportementale et électrophysiologie sur tranche d'hippocampe de souris : Interest of 5-HT4 receptors in Alzheimer’s disease : behavioral and electrophysiological preclinical studies on mice.

Degree: Docteur es, Aspects moleculaires et cellulaires de la biologie, 2018, Normandie

La Maladie d’Alzheimer (MA) est la première cause de démence au monde. Un fort coût de prise en charge, associé une faible efficacité des traitements… (more)

Subjects/Keywords: Plasticité synaptique; Système GABAergique; 5-HT4 receptors; Alzheimer's disease; Synaptic plasticity; GABAergic system; Galantamine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lecouflet, P. (2018). Intérêts des récepteurs 5-HT4 dans la pathologie Alzmeimer : étude préclinique comportementale et électrophysiologie sur tranche d'hippocampe de souris : Interest of 5-HT4 receptors in Alzheimer’s disease : behavioral and electrophysiological preclinical studies on mice. (Doctoral Dissertation). Normandie. Retrieved from http://www.theses.fr/2018NORMC415

Chicago Manual of Style (16th Edition):

Lecouflet, Pierre. “Intérêts des récepteurs 5-HT4 dans la pathologie Alzmeimer : étude préclinique comportementale et électrophysiologie sur tranche d'hippocampe de souris : Interest of 5-HT4 receptors in Alzheimer’s disease : behavioral and electrophysiological preclinical studies on mice.” 2018. Doctoral Dissertation, Normandie. Accessed January 23, 2020. http://www.theses.fr/2018NORMC415.

MLA Handbook (7th Edition):

Lecouflet, Pierre. “Intérêts des récepteurs 5-HT4 dans la pathologie Alzmeimer : étude préclinique comportementale et électrophysiologie sur tranche d'hippocampe de souris : Interest of 5-HT4 receptors in Alzheimer’s disease : behavioral and electrophysiological preclinical studies on mice.” 2018. Web. 23 Jan 2020.

Vancouver:

Lecouflet P. Intérêts des récepteurs 5-HT4 dans la pathologie Alzmeimer : étude préclinique comportementale et électrophysiologie sur tranche d'hippocampe de souris : Interest of 5-HT4 receptors in Alzheimer’s disease : behavioral and electrophysiological preclinical studies on mice. [Internet] [Doctoral dissertation]. Normandie; 2018. [cited 2020 Jan 23]. Available from: http://www.theses.fr/2018NORMC415.

Council of Science Editors:

Lecouflet P. Intérêts des récepteurs 5-HT4 dans la pathologie Alzmeimer : étude préclinique comportementale et électrophysiologie sur tranche d'hippocampe de souris : Interest of 5-HT4 receptors in Alzheimer’s disease : behavioral and electrophysiological preclinical studies on mice. [Doctoral Dissertation]. Normandie; 2018. Available from: http://www.theses.fr/2018NORMC415


Universidade do Rio Grande do Sul

6. Odorcyk, Felipe Kawa. Efeitos da administração de galantamina no modelo de hipóxia-isquemia neonatal em ratos.

Degree: 2015, Universidade do Rio Grande do Sul

A hipóxia-isquemia neonatal (HI) faz parte da etiologia de diversas patologias neurológicas e é causa de graves sequelas. Os mecanismos patofisiológicos dessa lesão começam com… (more)

Subjects/Keywords: Hipóxia-isquemia encefálica; Hypoxia ischemia (HI); Galantamina; Acetylcholinesterase (AChE); Galantamine; Neurônios colinérgicos; Inflammation; Acetilcolinesterase; Neuroprotection; Neuroproteção

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Odorcyk, F. K. (2015). Efeitos da administração de galantamina no modelo de hipóxia-isquemia neonatal em ratos. (Thesis). Universidade do Rio Grande do Sul. Retrieved from http://hdl.handle.net/10183/170266

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Odorcyk, Felipe Kawa. “Efeitos da administração de galantamina no modelo de hipóxia-isquemia neonatal em ratos.” 2015. Thesis, Universidade do Rio Grande do Sul. Accessed January 23, 2020. http://hdl.handle.net/10183/170266.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Odorcyk, Felipe Kawa. “Efeitos da administração de galantamina no modelo de hipóxia-isquemia neonatal em ratos.” 2015. Web. 23 Jan 2020.

Vancouver:

Odorcyk FK. Efeitos da administração de galantamina no modelo de hipóxia-isquemia neonatal em ratos. [Internet] [Thesis]. Universidade do Rio Grande do Sul; 2015. [cited 2020 Jan 23]. Available from: http://hdl.handle.net/10183/170266.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Odorcyk FK. Efeitos da administração de galantamina no modelo de hipóxia-isquemia neonatal em ratos. [Thesis]. Universidade do Rio Grande do Sul; 2015. Available from: http://hdl.handle.net/10183/170266

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Temple University

7. Ganti, Satyakala. DEVELOPMENT OF HPLC METHODS FOR PHARMACEUTICALLY RELEVANT MOLECULES; METHOD TRANSFER TO UPLC: COMPARING METHODS STATISTICALLY FOR EQUIVALENCE.

Degree: PhD, 2011, Temple University

Chemistry

High Pressure Liquid Chromatography (HPLC) is a well-known and widely used analytical technique which is prevalent throughout the pharmaceutical industry as a research tool.… (more)

Subjects/Keywords: Analytical Chemistry; Galantamine; HPLC: High Pressure Liquid Chromatography; Method Comparison; Statistical Analysis; UHPLC: Ultra High Pressure Liquid Chromatography

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ganti, S. (2011). DEVELOPMENT OF HPLC METHODS FOR PHARMACEUTICALLY RELEVANT MOLECULES; METHOD TRANSFER TO UPLC: COMPARING METHODS STATISTICALLY FOR EQUIVALENCE. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,118587

Chicago Manual of Style (16th Edition):

Ganti, Satyakala. “DEVELOPMENT OF HPLC METHODS FOR PHARMACEUTICALLY RELEVANT MOLECULES; METHOD TRANSFER TO UPLC: COMPARING METHODS STATISTICALLY FOR EQUIVALENCE.” 2011. Doctoral Dissertation, Temple University. Accessed January 23, 2020. http://digital.library.temple.edu/u?/p245801coll10,118587.

MLA Handbook (7th Edition):

Ganti, Satyakala. “DEVELOPMENT OF HPLC METHODS FOR PHARMACEUTICALLY RELEVANT MOLECULES; METHOD TRANSFER TO UPLC: COMPARING METHODS STATISTICALLY FOR EQUIVALENCE.” 2011. Web. 23 Jan 2020.

Vancouver:

Ganti S. DEVELOPMENT OF HPLC METHODS FOR PHARMACEUTICALLY RELEVANT MOLECULES; METHOD TRANSFER TO UPLC: COMPARING METHODS STATISTICALLY FOR EQUIVALENCE. [Internet] [Doctoral dissertation]. Temple University; 2011. [cited 2020 Jan 23]. Available from: http://digital.library.temple.edu/u?/p245801coll10,118587.

Council of Science Editors:

Ganti S. DEVELOPMENT OF HPLC METHODS FOR PHARMACEUTICALLY RELEVANT MOLECULES; METHOD TRANSFER TO UPLC: COMPARING METHODS STATISTICALLY FOR EQUIVALENCE. [Doctoral Dissertation]. Temple University; 2011. Available from: http://digital.library.temple.edu/u?/p245801coll10,118587


University of Ottawa

8. Biard, Kathleen. Effects of Pharmacological Manipulation of the Serotonergic/Cholinergic Systems on Sleep Structure in Two 5-HT1A Genotypes: Implications for a Model of Depression .

Degree: 2015, University of Ottawa

 The serotonergic and cholinergic systems are jointly involved in regulating sleep but this balance is theorized to be disturbed in depressed individuals (Janowsky 1972, Jouvet… (more)

Subjects/Keywords: Sleep; Depression; Sleep structure; REM; serotonin; acetylcholine; buspirone; galantamine; neurotransmission; 5-HT1A receptor; genetic risk factors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Biard, K. (2015). Effects of Pharmacological Manipulation of the Serotonergic/Cholinergic Systems on Sleep Structure in Two 5-HT1A Genotypes: Implications for a Model of Depression . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/33005

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Biard, Kathleen. “Effects of Pharmacological Manipulation of the Serotonergic/Cholinergic Systems on Sleep Structure in Two 5-HT1A Genotypes: Implications for a Model of Depression .” 2015. Thesis, University of Ottawa. Accessed January 23, 2020. http://hdl.handle.net/10393/33005.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Biard, Kathleen. “Effects of Pharmacological Manipulation of the Serotonergic/Cholinergic Systems on Sleep Structure in Two 5-HT1A Genotypes: Implications for a Model of Depression .” 2015. Web. 23 Jan 2020.

Vancouver:

Biard K. Effects of Pharmacological Manipulation of the Serotonergic/Cholinergic Systems on Sleep Structure in Two 5-HT1A Genotypes: Implications for a Model of Depression . [Internet] [Thesis]. University of Ottawa; 2015. [cited 2020 Jan 23]. Available from: http://hdl.handle.net/10393/33005.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Biard K. Effects of Pharmacological Manipulation of the Serotonergic/Cholinergic Systems on Sleep Structure in Two 5-HT1A Genotypes: Implications for a Model of Depression . [Thesis]. University of Ottawa; 2015. Available from: http://hdl.handle.net/10393/33005

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Queens University

9. Fong, Raymond. Cholinesterase Inhibitors: A population-based assessment of resource utilization for patients with Alzheimer's dementia in Ontario .

Degree: Community Health and Epidemiology, 2011, Queens University

 Background: Dementia leads to progressive cognitive and functional decline. Population aging is a concern, and the healthcare system must refocus its limited resources to keep… (more)

Subjects/Keywords: Alzheimer's; Dementia; Cholinesterase Inhibitors; Donepezil; Galantamine; Rivastigmine; Resource Utilization; Ontario; Cost-Minimization; Comparative Study; Epidemiology; Economics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fong, R. (2011). Cholinesterase Inhibitors: A population-based assessment of resource utilization for patients with Alzheimer's dementia in Ontario . (Thesis). Queens University. Retrieved from http://hdl.handle.net/1974/6857

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fong, Raymond. “Cholinesterase Inhibitors: A population-based assessment of resource utilization for patients with Alzheimer's dementia in Ontario .” 2011. Thesis, Queens University. Accessed January 23, 2020. http://hdl.handle.net/1974/6857.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fong, Raymond. “Cholinesterase Inhibitors: A population-based assessment of resource utilization for patients with Alzheimer's dementia in Ontario .” 2011. Web. 23 Jan 2020.

Vancouver:

Fong R. Cholinesterase Inhibitors: A population-based assessment of resource utilization for patients with Alzheimer's dementia in Ontario . [Internet] [Thesis]. Queens University; 2011. [cited 2020 Jan 23]. Available from: http://hdl.handle.net/1974/6857.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fong R. Cholinesterase Inhibitors: A population-based assessment of resource utilization for patients with Alzheimer's dementia in Ontario . [Thesis]. Queens University; 2011. Available from: http://hdl.handle.net/1974/6857

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

10. Κανή, Χαρίκλεια. Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση.

Degree: 2009, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

 To examine whether Cholinesterase Inhibitors (ChEIs) and memantine are superior to placebo in the treatment a) of Alzheimer’s disease (AD) for at least 6 months… (more)

Subjects/Keywords: Δονεπεζίλη; Γκαλανταμίνη; Ριβαστιγμίνη; Μεμαντίνη; Νόσος Alzheimer; Άνοια, Αγγειακή; Συστηματική ανασκόπηση; Μετά - ανάλυση; Donepezil; Galantamine; Rivastigmine; Memantine; Alzheimer's disease; Vascular dementia; Systematic review; Meta - analysis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Κανή, . . (2009). Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/19819

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Κανή, Χαρίκλεια. “Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση.” 2009. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed January 23, 2020. http://hdl.handle.net/10442/hedi/19819.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Κανή, Χαρίκλεια. “Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση.” 2009. Web. 23 Jan 2020.

Vancouver:

Κανή . Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2009. [cited 2020 Jan 23]. Available from: http://hdl.handle.net/10442/hedi/19819.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Κανή . Εκτίμηση ασφάλειας και αποτελεσματικότητας των φαρμάκων που χρησιμοποιούνται στην αντιμετώπιση της άνοιας: μετα-ανάλυση. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2009. Available from: http://hdl.handle.net/10442/hedi/19819

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Vrije Universiteit Amsterdam

11. Goekoop, R. Pharmacological fMRI; a clinical exploration .

Degree: 2006, Vrije Universiteit Amsterdam

 Dit proefschrift beschrijft de resultaten van een verkennend onderzoek naar een nieuwe techniek die gebruikt kan worden om de effecten van geneesmiddelen op hersenaktiviteit af… (more)

Subjects/Keywords: Pharmacological fMRI; a clinical exploration; Farmacologie; fMRI; Geheugen; Alzheimer; emotie; galantamine; propranolol; raloxifene

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Goekoop, R. (2006). Pharmacological fMRI; a clinical exploration . (Doctoral Dissertation). Vrije Universiteit Amsterdam. Retrieved from http://hdl.handle.net/1871/9069

Chicago Manual of Style (16th Edition):

Goekoop, R. “Pharmacological fMRI; a clinical exploration .” 2006. Doctoral Dissertation, Vrije Universiteit Amsterdam. Accessed January 23, 2020. http://hdl.handle.net/1871/9069.

MLA Handbook (7th Edition):

Goekoop, R. “Pharmacological fMRI; a clinical exploration .” 2006. Web. 23 Jan 2020.

Vancouver:

Goekoop R. Pharmacological fMRI; a clinical exploration . [Internet] [Doctoral dissertation]. Vrije Universiteit Amsterdam; 2006. [cited 2020 Jan 23]. Available from: http://hdl.handle.net/1871/9069.

Council of Science Editors:

Goekoop R. Pharmacological fMRI; a clinical exploration . [Doctoral Dissertation]. Vrije Universiteit Amsterdam; 2006. Available from: http://hdl.handle.net/1871/9069


University of Debrecen

12. Choi, Hyun Duck. Pharmacological and Clinical Review of AchEI against NMDA antagonist in treatment of Alzheimer Dementia .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 To date, there are only symptomatic treatments approved by the FDA and in wide clinical usage: Rivastigmine, Galantamine, Donepezil, and Memantine. However, their actual clinical… (more)

Subjects/Keywords: Alzheimer; Dementia; Efficacy; Safety; Tolerability; Comparison; AchEI; NMDA antagonist; Acetylcholinesterase inhibitor; Pharmacological; Clinical; treatment; Review; Memantine; Donepezil; Rivastigmine; Galantamine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Choi, H. D. (n.d.). Pharmacological and Clinical Review of AchEI against NMDA antagonist in treatment of Alzheimer Dementia . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/242811

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Choi, Hyun Duck. “Pharmacological and Clinical Review of AchEI against NMDA antagonist in treatment of Alzheimer Dementia .” Thesis, University of Debrecen. Accessed January 23, 2020. http://hdl.handle.net/2437/242811.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Choi, Hyun Duck. “Pharmacological and Clinical Review of AchEI against NMDA antagonist in treatment of Alzheimer Dementia .” Web. 23 Jan 2020.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Choi HD. Pharmacological and Clinical Review of AchEI against NMDA antagonist in treatment of Alzheimer Dementia . [Internet] [Thesis]. University of Debrecen; [cited 2020 Jan 23]. Available from: http://hdl.handle.net/2437/242811.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Choi HD. Pharmacological and Clinical Review of AchEI against NMDA antagonist in treatment of Alzheimer Dementia . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/242811

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


Pontifical Catholic University of Rio de Janeiro

13. ANA PAULA LAMOUNIER. [en] MICELLAR LIQUID CHROMATOGRAPHY WITH FLUORIMETRIC DETECTION FOR THE DETERMINATION OF SIX B-CARBOLINE ALKALOIDS AND GALANTAMINE IN THE PRESENCE OF ITS MAJOR METABOLITES.

Degree: 2016, Pontifical Catholic University of Rio de Janeiro

 [pt] Métodos baseados na cromatografia líquida micelar (MLC) com detecção fluorimétrica foram desenvolvidos para dois estudos de caso. No primeiro deles, seis B-carbolinas (harmol, harmalol,… (more)

Subjects/Keywords: [pt] URINA; [en] URINE; [pt] CROMATOGRAFIA LIQUIDA MICELAR; [en] MICELLAR LIQUID CHROMATOGRAPHY; [pt] ALCALOIDES B CARBOLINAS; [en] B CARBOLINE ALKALOIDS; [pt] GALANTAMINA E METABOLITOS; [en] GALANTAMINE AND METABOLITES; [pt] DETECCAO FLUORIMETRICA; [en] FLUORIMETRIC DETECTION; [pt] EXTRATOS FITOTERAPICOS; [en] PHYTOTHERAPIC EXTRACTS

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

LAMOUNIER, A. P. (2016). [en] MICELLAR LIQUID CHROMATOGRAPHY WITH FLUORIMETRIC DETECTION FOR THE DETERMINATION OF SIX B-CARBOLINE ALKALOIDS AND GALANTAMINE IN THE PRESENCE OF ITS MAJOR METABOLITES. (Thesis). Pontifical Catholic University of Rio de Janeiro. Retrieved from http://www.maxwell.vrac.puc-rio.br/Busca_etds.php?strSecao=resultado&nrSeq=26817

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

LAMOUNIER, ANA PAULA. “[en] MICELLAR LIQUID CHROMATOGRAPHY WITH FLUORIMETRIC DETECTION FOR THE DETERMINATION OF SIX B-CARBOLINE ALKALOIDS AND GALANTAMINE IN THE PRESENCE OF ITS MAJOR METABOLITES.” 2016. Thesis, Pontifical Catholic University of Rio de Janeiro. Accessed January 23, 2020. http://www.maxwell.vrac.puc-rio.br/Busca_etds.php?strSecao=resultado&nrSeq=26817.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

LAMOUNIER, ANA PAULA. “[en] MICELLAR LIQUID CHROMATOGRAPHY WITH FLUORIMETRIC DETECTION FOR THE DETERMINATION OF SIX B-CARBOLINE ALKALOIDS AND GALANTAMINE IN THE PRESENCE OF ITS MAJOR METABOLITES.” 2016. Web. 23 Jan 2020.

Vancouver:

LAMOUNIER AP. [en] MICELLAR LIQUID CHROMATOGRAPHY WITH FLUORIMETRIC DETECTION FOR THE DETERMINATION OF SIX B-CARBOLINE ALKALOIDS AND GALANTAMINE IN THE PRESENCE OF ITS MAJOR METABOLITES. [Internet] [Thesis]. Pontifical Catholic University of Rio de Janeiro; 2016. [cited 2020 Jan 23]. Available from: http://www.maxwell.vrac.puc-rio.br/Busca_etds.php?strSecao=resultado&nrSeq=26817.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

LAMOUNIER AP. [en] MICELLAR LIQUID CHROMATOGRAPHY WITH FLUORIMETRIC DETECTION FOR THE DETERMINATION OF SIX B-CARBOLINE ALKALOIDS AND GALANTAMINE IN THE PRESENCE OF ITS MAJOR METABOLITES. [Thesis]. Pontifical Catholic University of Rio de Janeiro; 2016. Available from: http://www.maxwell.vrac.puc-rio.br/Busca_etds.php?strSecao=resultado&nrSeq=26817

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

14. O'Regan, Jordana. Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer’s Disease in a Long Term Care Setting.

Degree: 2014, University of Toronto

Cholinesterase inhibitors (ChEIs) are the first line pharmacotherapy for the symptoms of Alzheimer’s disease (AD). Though ChEIs offer modest cognitive benefits in early AD, literature… (more)

Subjects/Keywords: Alzheimer's Disease; cholinesterase inhibitors; discontinuation; cessation; donepezil; rivastigmine; galantamine; ChEIs; 0419

…procedure for donepezil ...53 Figure IV: Administration procedure for galantamine… …Edition GAL – galantamine iADL– instrumental activities of daily living ITT – intention-to-treat… …Problem Cholinesterase inhibitors (ChEIs) donepezil, galantamine and rivastigmine are… …galantamine and rivastigmine are used more routinely in clinical practice. The pharmacological… …ChEI approved for use in all stages of AD. Galantamine and rivastigmine were approved shortly… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

O'Regan, J. (2014). Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer’s Disease in a Long Term Care Setting. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/44051

Chicago Manual of Style (16th Edition):

O'Regan, Jordana. “Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer’s Disease in a Long Term Care Setting.” 2014. Masters Thesis, University of Toronto. Accessed January 23, 2020. http://hdl.handle.net/1807/44051.

MLA Handbook (7th Edition):

O'Regan, Jordana. “Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer’s Disease in a Long Term Care Setting.” 2014. Web. 23 Jan 2020.

Vancouver:

O'Regan J. Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer’s Disease in a Long Term Care Setting. [Internet] [Masters thesis]. University of Toronto; 2014. [cited 2020 Jan 23]. Available from: http://hdl.handle.net/1807/44051.

Council of Science Editors:

O'Regan J. Assessing the Safety of Cholinesterase Inhibitor Discontinuation in Patients with Moderate to Severe Alzheimer’s Disease in a Long Term Care Setting. [Masters Thesis]. University of Toronto; 2014. Available from: http://hdl.handle.net/1807/44051


Freie Universität Berlin

15. Baumann, Lisa Katharina. The importance of biomarkers for the progression of the Alzheimer’s disease.

Degree: 2019, Freie Universität Berlin

 Background: Mild cognitive impairment (MCI) clinically precedes Alzheimer’s dementia (AD). For AD a symptomatic treatment with acetylcholinesterase-inhibitors (AChE-I) and the N-Methyl-D-Aspartat Receptor antagonist memantin is… (more)

Subjects/Keywords: Acetylcholinesterase inhibitor; amyloid β1-42; Cerebrospinal fluid; Combination treatment; Dementia; Florbetaben; Galantamine; hippocampal atrophy; Memantine; PET-tracer; total-Tau; Mild Cognitive Impairment; 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Baumann, L. K. (2019). The importance of biomarkers for the progression of the Alzheimer’s disease. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-4207

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Baumann, Lisa Katharina. “The importance of biomarkers for the progression of the Alzheimer’s disease.” 2019. Thesis, Freie Universität Berlin. Accessed January 23, 2020. http://dx.doi.org/10.17169/refubium-4207.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Baumann, Lisa Katharina. “The importance of biomarkers for the progression of the Alzheimer’s disease.” 2019. Web. 23 Jan 2020.

Vancouver:

Baumann LK. The importance of biomarkers for the progression of the Alzheimer’s disease. [Internet] [Thesis]. Freie Universität Berlin; 2019. [cited 2020 Jan 23]. Available from: http://dx.doi.org/10.17169/refubium-4207.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Baumann LK. The importance of biomarkers for the progression of the Alzheimer’s disease. [Thesis]. Freie Universität Berlin; 2019. Available from: http://dx.doi.org/10.17169/refubium-4207

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

16. Sarwary, Mariam. Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine.

Degree: Pharmacology, 2017, Umeå University

Subjects/Keywords: Alzheimer´s disease; Donepezil; Rivastigmine; Galantamine; Memantine and randomized controlled trails; Pharmaceutical Sciences; Farmaceutiska vetenskaper

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sarwary, M. (2017). Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine. (Thesis). Umeå University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136250

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sarwary, Mariam. “Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine.” 2017. Thesis, Umeå University. Accessed January 23, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136250.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sarwary, Mariam. “Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine.” 2017. Web. 23 Jan 2020.

Vancouver:

Sarwary M. Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine. [Internet] [Thesis]. Umeå University; 2017. [cited 2020 Jan 23]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136250.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sarwary M. Comparison of cognitive decline medications of Alzheimer´s disease : Efficacy and safety of Donepezil, Galantamine, Rivastigmine and Memantine. [Thesis]. Umeå University; 2017. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136250

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

17. Robinson, Jessica. Characterizing the Role of Acetylcholinesterase in Mouse Cardiomyoctyte Proliferation and Differentiation.

Degree: MS, Department of Pharmacology, 2013, Dalhousie University

 There is scarce information on the fate of cardiac progenitor cells (CPC) in the embryonic heart after chamber specification. Furthermore, the role of acetylcholinesterase (AChE)… (more)

Subjects/Keywords: Acetylcholinesterase; AChE; AChE-R; readthrough; cardiac conduction; VCS; cardiac cell proliferation; cardiac cell differentiation; cardiac development; conduction cell development; galantamine

…of CPC populations. Lastly, exogenous addition of the AChE inhibitor galantamine to… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Robinson, J. (2013). Characterizing the Role of Acetylcholinesterase in Mouse Cardiomyoctyte Proliferation and Differentiation. (Masters Thesis). Dalhousie University. Retrieved from http://hdl.handle.net/10222/42718

Chicago Manual of Style (16th Edition):

Robinson, Jessica. “Characterizing the Role of Acetylcholinesterase in Mouse Cardiomyoctyte Proliferation and Differentiation.” 2013. Masters Thesis, Dalhousie University. Accessed January 23, 2020. http://hdl.handle.net/10222/42718.

MLA Handbook (7th Edition):

Robinson, Jessica. “Characterizing the Role of Acetylcholinesterase in Mouse Cardiomyoctyte Proliferation and Differentiation.” 2013. Web. 23 Jan 2020.

Vancouver:

Robinson J. Characterizing the Role of Acetylcholinesterase in Mouse Cardiomyoctyte Proliferation and Differentiation. [Internet] [Masters thesis]. Dalhousie University; 2013. [cited 2020 Jan 23]. Available from: http://hdl.handle.net/10222/42718.

Council of Science Editors:

Robinson J. Characterizing the Role of Acetylcholinesterase in Mouse Cardiomyoctyte Proliferation and Differentiation. [Masters Thesis]. Dalhousie University; 2013. Available from: http://hdl.handle.net/10222/42718


Virginia Commonwealth University

18. Lee, David. Age-Related Differences in In-vitro Sensitivity to Inhibition of Human Red Blood Cell Acetylcholinesterase and Plasma Butyrylcholinesterase by the Cholinesterase Inhibitors Physostigmine (PHYS), Pyridostigmine (PYR), Donepezil (DON) and Galantamine (GAL).

Degree: PhD, Pharmaceutics, 2009, Virginia Commonwealth University

 Alzheimer’s disease (AD) is a chronic, progressive neurodegenerative disorder, characterized clinically by a progressive loss of memory, cognitive function, ability to care for oneself and… (more)

Subjects/Keywords: acetylcholinesterase; butyrylcholinesterase; cholinesterase inhibitors; aging; in-vitro sensitivity; physostigmine; galantamine; donepezil; pyridostigmine; red blood cell; plasma; age-related; suicide inactivator; competitive inhibitors; noncompetitive inhibitors; mechanism-based inhibitor; inhibitor models; enzyme kinetics; inhibitor kinetics; Alzheimer’s disease; myathenia gravis; Medicine and Health Sciences; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lee, D. (2009). Age-Related Differences in In-vitro Sensitivity to Inhibition of Human Red Blood Cell Acetylcholinesterase and Plasma Butyrylcholinesterase by the Cholinesterase Inhibitors Physostigmine (PHYS), Pyridostigmine (PYR), Donepezil (DON) and Galantamine (GAL). (Doctoral Dissertation). Virginia Commonwealth University. Retrieved from https://scholarscompass.vcu.edu/etd/1937

Chicago Manual of Style (16th Edition):

Lee, David. “Age-Related Differences in In-vitro Sensitivity to Inhibition of Human Red Blood Cell Acetylcholinesterase and Plasma Butyrylcholinesterase by the Cholinesterase Inhibitors Physostigmine (PHYS), Pyridostigmine (PYR), Donepezil (DON) and Galantamine (GAL).” 2009. Doctoral Dissertation, Virginia Commonwealth University. Accessed January 23, 2020. https://scholarscompass.vcu.edu/etd/1937.

MLA Handbook (7th Edition):

Lee, David. “Age-Related Differences in In-vitro Sensitivity to Inhibition of Human Red Blood Cell Acetylcholinesterase and Plasma Butyrylcholinesterase by the Cholinesterase Inhibitors Physostigmine (PHYS), Pyridostigmine (PYR), Donepezil (DON) and Galantamine (GAL).” 2009. Web. 23 Jan 2020.

Vancouver:

Lee D. Age-Related Differences in In-vitro Sensitivity to Inhibition of Human Red Blood Cell Acetylcholinesterase and Plasma Butyrylcholinesterase by the Cholinesterase Inhibitors Physostigmine (PHYS), Pyridostigmine (PYR), Donepezil (DON) and Galantamine (GAL). [Internet] [Doctoral dissertation]. Virginia Commonwealth University; 2009. [cited 2020 Jan 23]. Available from: https://scholarscompass.vcu.edu/etd/1937.

Council of Science Editors:

Lee D. Age-Related Differences in In-vitro Sensitivity to Inhibition of Human Red Blood Cell Acetylcholinesterase and Plasma Butyrylcholinesterase by the Cholinesterase Inhibitors Physostigmine (PHYS), Pyridostigmine (PYR), Donepezil (DON) and Galantamine (GAL). [Doctoral Dissertation]. Virginia Commonwealth University; 2009. Available from: https://scholarscompass.vcu.edu/etd/1937

19. Muriithi, Paul Mutuanyingi. A case for memory enhancement : ethical, social, legal, and policy implications for enhancing the memory.

Degree: PhD, 2014, University of Manchester

 The desire to enhance and make ourselves better is not a new one and it has continued to intrigue throughout the ages. Individuals have continued… (more)

Subjects/Keywords: 174; adderall; ampakines; amphetamine; appeal to empathy; aricept; Aristotle; Baddeley; benzodiazepines; bioethics; Bostrom; brain stimulation; brain-computer interface; brain-machine interface; Brunet; Buchanan; caffeine; Cahil; Caplan; case; coercion; computers; confidentiality; consent; consequentialist; consistency; consolidation; conventional; criminal; damages; d-amphetamine; declarative memory; deep brain stimulation; Degrazia; deontological; diazepam; discrimination; donepezil; Douglas; drug mongering; duty; duty to remember; Dworkin; electroconvulsive therapy; Elliott; emotional distress; emotions; encoding; enhancement; enhancing technologies; epistemic knowledge; equality; ethical; evidence; exelon; explicit memory; eyewitness; eyewitness evidence; eyewitness testimony; Facebook; Farah; forget; Fukuyama; galantamine; gatekeepers; Ghetti; ginkgo biloba; Glover; glucocorticoids; glucose; greater good; Habermas; Harris; health; human dignity; human diversity; human enhancement; human nature; human rights; Hunter; identity; implicit memory; inauthentic; individual autonomy; inevitable; informed consent; internet; Jackson; justice; Kamm; Kass; Kolber; laissez faire; learning; legal; legal approach; lifelogging; living authentically; Loftus; long-term memory; Lynch; malleability of memory; mastery; McKibben; medicalization; meditation; Mehlman; Meilaender; memantine; Memory; memory dampening; memory enhancement; memory manipulation; memory processes; memory retention; memory retrieval; memory storage; methylphenidate; midazalom; misidentification of witnesses; mistaken identifications; mitigation; mnemonics; modafinil; moratorium; music; negative emotions; negligence; nondeclarative memory; non-pharmacological memory enhancement; nutrition; obligation; obstruction of justice; omega-3; optimum memory; Parens; person identity; personality; perverting justice; pharmacological means; philosophical approach; photographic; physical exercise; Pitman; policy; poly unsaturated fatty acids; precautionary approach; precautionary principle; preserving memories; President’s Council; primary memory; privacy; procedural memory; propofol; propranolol; provigil; razadyne; recall; recording audio; reference memory; regulation; regulatory authorities; regulatory bodies; relational memory; remembering; remembering fitly; remembering truly; risks; ritalin; rites; rituals; rivastigmine; safety; Sahakian; Sandberg; Sandel; Savulescu; Schacter; secondary memory; short-term memory; sleep; slippery slope; social; societies' interests; species-typical; society interests; species-typical functioning; Squire; Stanton; Strange; technological means; testimony; therapeutic; therapy; therapy-enhancement distinction; traditional; transcrannial direct current stimulation; transcrannial magnetic stimulation; traumatic memories; Tulving; ultimate prize; unnatural; unnatural means; Vaiva; video devices; virtual social networking; virtue ethics; Wagenaar; well-being; Wells; working memory; wrongful; wrongful acquittals; wrongful convictions; yoga; Kahane; Giordano; Bennett; Holm; Mental Capacity Act

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Muriithi, P. M. (2014). A case for memory enhancement : ethical, social, legal, and policy implications for enhancing the memory. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/a-case-for-memory-enhancement-ethical-social-legal-and-policy-implications-for-enhancing-the-memory(bf11d09d-6326-49d2-8ef3-a40340471acf).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.603223

Chicago Manual of Style (16th Edition):

Muriithi, Paul Mutuanyingi. “A case for memory enhancement : ethical, social, legal, and policy implications for enhancing the memory.” 2014. Doctoral Dissertation, University of Manchester. Accessed January 23, 2020. https://www.research.manchester.ac.uk/portal/en/theses/a-case-for-memory-enhancement-ethical-social-legal-and-policy-implications-for-enhancing-the-memory(bf11d09d-6326-49d2-8ef3-a40340471acf).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.603223.

MLA Handbook (7th Edition):

Muriithi, Paul Mutuanyingi. “A case for memory enhancement : ethical, social, legal, and policy implications for enhancing the memory.” 2014. Web. 23 Jan 2020.

Vancouver:

Muriithi PM. A case for memory enhancement : ethical, social, legal, and policy implications for enhancing the memory. [Internet] [Doctoral dissertation]. University of Manchester; 2014. [cited 2020 Jan 23]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/a-case-for-memory-enhancement-ethical-social-legal-and-policy-implications-for-enhancing-the-memory(bf11d09d-6326-49d2-8ef3-a40340471acf).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.603223.

Council of Science Editors:

Muriithi PM. A case for memory enhancement : ethical, social, legal, and policy implications for enhancing the memory. [Doctoral Dissertation]. University of Manchester; 2014. Available from: https://www.research.manchester.ac.uk/portal/en/theses/a-case-for-memory-enhancement-ethical-social-legal-and-policy-implications-for-enhancing-the-memory(bf11d09d-6326-49d2-8ef3-a40340471acf).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.603223

20. Muriithi, Paul Mutuanyingi. A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory.

Degree: 2014, University of Manchester

 The desire to enhance and make ourselves better is not a new one and it has continued to intrigue throughout the ages. Individuals have continued… (more)

Subjects/Keywords: adderall; ampakines; amphetamine; appeal to empathy; aricept; Aristotle; Baddeley; benzodiazepines; bioethics; Bostrom; brain stimulation; brain-computer interface; brain-machine interface; Brunet; Buchanan; caffeine; Cahil; Caplan; case; coercion; computers; confidentiality; consent; consequentialist; consistency; consolidation; conventional; criminal; damages; d-amphetamine; declarative memory; deep brain stimulation; Degrazia; deontological; diazepam; discrimination; donepezil; Douglas; drug mongering; duty; duty to remember; Dworkin; electroconvulsive therapy; Elliott; emotional distress; emotions; encoding; enhancement; enhancing technologies; epistemic knowledge; equality; ethical; evidence; exelon; explicit memory; eyewitness; eyewitness evidence; eyewitness testimony; Facebook; Farah; forget; Fukuyama; galantamine; gatekeepers; Ghetti; ginkgo biloba; Glover; glucocorticoids; glucose; greater good; Habermas; Harris; health; human dignity; human diversity; human enhancement; human nature; human rights; Hunter; identity; implicit memory; inauthentic; individual autonomy; inevitable; informed consent; internet; Jackson; justice; Kamm; Kass; Kolber; laissez faire; learning; legal; legal approach; lifelogging; living authentically; Loftus; long-term memory; Lynch; malleability of memory; mastery; McKibben; medicalization; meditation; Mehlman; Meilaender; memantine; Memory; memory dampening; memory enhancement; memory manipulation; memory processes; memory retention; memory retrieval; memory storage; methylphenidate; midazalom; misidentification of witnesses; mistaken identifications; mitigation; mnemonics; modafinil; moratorium; music; negative emotions; negligence; nondeclarative memory; non-pharmacological memory enhancement; nutrition; obligation; obstruction of justice; omega-3; optimum memory; Parens; person identity; personality; perverting justice; pharmacological means; philosophical approach; photographic; physical exercise; Pitman; policy; poly unsaturated fatty acids; precautionary approach; precautionary principle; preserving memories; President’s Council; primary memory; privacy; procedural memory; propofol; propranolol; provigil; razadyne; recall; recording audio; reference memory; regulation; regulatory authorities; regulatory bodies; relational memory; remembering; remembering fitly; remembering truly; risks; ritalin; rites; rituals; rivastigmine; safety; Sahakian; Sandberg; Sandel; Savulescu; Schacter; secondary memory; short-term memory; sleep; slippery slope; social; societies' interests; species-typical; society interests; species-typical functioning; Squire; Stanton; Strange; technological means; testimony; therapeutic; therapy; therapy-enhancement distinction; traditional; transcrannial direct current stimulation; transcrannial magnetic stimulation; traumatic memories; Tulving; ultimate prize; unnatural; unnatural means; Vaiva; video devices; virtual social networking; virtue ethics; Wagenaar; well-being; Wells; working memory; wrongful; wrongful acquittals; wrongful convictions; yoga; Kahane; Giordano; Bennett; Holm; Mental Capacity Act

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Muriithi, P. M. (2014). A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:220498

Chicago Manual of Style (16th Edition):

Muriithi, Paul Mutuanyingi. “A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory.” 2014. Doctoral Dissertation, University of Manchester. Accessed January 23, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:220498.

MLA Handbook (7th Edition):

Muriithi, Paul Mutuanyingi. “A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory.” 2014. Web. 23 Jan 2020.

Vancouver:

Muriithi PM. A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory. [Internet] [Doctoral dissertation]. University of Manchester; 2014. [cited 2020 Jan 23]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:220498.

Council of Science Editors:

Muriithi PM. A Case for Memory Enhancement: Ethical, Social, Legal, and Policy Implications for Enhancing the Memory. [Doctoral Dissertation]. University of Manchester; 2014. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:220498

.